Prospective Randomized Controlled Trail of the Effects of Steroids on Swallowing, Airway and Arthrodesis Related to Myulti-Level Anterior Cervical Reconstruction
Overview
- Phase
- Phase 1
- Intervention
- Saline
- Conditions
- Swallowing
- Sponsor
- Albany Medical College
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- subjects will demonstrate good bony fusion
- Last Updated
- 16 years ago
Overview
Brief Summary
Anterior cervical discectomy and fusion with or without decompression is a well-established surgical treatment for spine patients with the appropriate indications. Anterior approach involves some retraction that affect the midline structures of the anterior neck. Irritation and swelling may result, leading to postoperative dysphagia and the less common but critically important occurrence of postoperative airway compromise. Steroids given intraoperatively may reduce the incidence of these adverse outcomes by reducing the degree of swelling within the anterior neck subsequent to local surgical tissue trauma.
The investigators hypothesize that the use of steroids intraoperatively provides a significant benefit to the patient, in terms of reduced incidence of dysphagia and airway compromise.
Investigators
Eligibility Criteria
Inclusion Criteria
- •18 years of age or greater
- •Cervical spondylosis requiring surgical treatment at 2 or more motion segments
- •Ventrally - approachable vertebral levels
Exclusion Criteria
- •Minors (under 18 years old)
- •Pregnant women
- •Patients currently taking steroids
- •Patients requiring surgical treatment at only one segment
- •Comatose or incapacitated patients who cannot consent to participate
- •Wards of the state
- •Persons with an allergy to dexamethasone or related drugs
- •Persons employed at Albany Medical Center
Arms & Interventions
Saline
subject will be given a blinded dose of placebo saline intraoperatively followed by placebo doses every 6 hours for 24 hours.
Intervention: Saline
Decadron
Subject will be given Decadron 0.2mg/kg intraoperatively. This dose will be followed by 4 mg. every 6 hours for the first 24 hours.
Intervention: Decadron
Outcomes
Primary Outcomes
subjects will demonstrate good bony fusion
Time Frame: one year